Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05998759Phase 2Recruiting
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Connective Tissue DiseasesThrombocytopenia
PrincipalinvestigatorStart date: 2023-12-02

Research Network

Collaboration Network

24 collaborators·71 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Anbin Huang, MD.

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
1 trials

Shared therapeutic areas:

Connective Tissue DiseasesThrombocytopenia

Worked with same sponsors:

Beijing HospitalChanghai Hospital+21 more
Collaborated on 1 trial
Similarity Score24%

Wei Wei, MD.

Tianjin Medical University General Hospital

Related
1 trials

Shared therapeutic areas:

Connective Tissue DiseasesThrombocytopenia

Worked with same sponsors:

Beijing HospitalChanghai Hospital+21 more
Collaborated on 1 trial
Similarity Score24%

Qibing Xie, MD.

West China Hospital

Related
1 trials

Shared therapeutic areas:

Connective Tissue DiseasesThrombocytopenia

Worked with same sponsors:

Beijing HospitalChanghai Hospital+21 more
Collaborated on 1 trial
Similarity Score24%

Fen Li, MD.

Second Xiangya Hospital of Central South University

Related
1 trials

Shared therapeutic areas:

Connective Tissue DiseasesThrombocytopenia

Worked with same sponsors:

Beijing HospitalChanghai Hospital+21 more
Collaborated on 1 trial
Similarity Score24%

Hongbin Li, MD.

The Affiliated Hospital of Inner Mongolia Medical University

Related
1 trials

Shared therapeutic areas:

Connective Tissue DiseasesThrombocytopenia

Worked with same sponsors:

Beijing HospitalChanghai Hospital+21 more
Collaborated on 1 trial
Similarity Score24%

Hongsheng Sun, MD.

Shandong Provincial Hospital

Related
1 trials

Shared therapeutic areas:

Connective Tissue DiseasesThrombocytopenia

Worked with same sponsors:

Beijing HospitalChanghai Hospital+21 more
Collaborated on 1 trial
Similarity Score24%

Jing He, MD.

Peking University People's Hospital

Related
1 trials

Shared therapeutic areas:

Connective Tissue DiseasesThrombocytopenia

Worked with same sponsors:

Beijing HospitalChanghai Hospital+21 more
Collaborated on 1 trial
Similarity Score24%

Rong Mu, MD.

Peking University Third Hospital

Related
1 trials

Shared therapeutic areas:

Connective Tissue DiseasesThrombocytopenia

Worked with same sponsors:

Beijing HospitalChanghai Hospital+21 more
Collaborated on 1 trial
Similarity Score24%

Xuan Zhang, MD.

Beijing Hospital

Related
1 trials

Shared therapeutic areas:

Connective Tissue DiseasesThrombocytopenia

Worked with same sponsors:

Beijing HospitalChanghai Hospital+21 more
Collaborated on 1 trial
Similarity Score24%

Yongjing Cheng, MD.

Beijing Hospital

Related
1 trials

Shared therapeutic areas:

Connective Tissue DiseasesThrombocytopenia

Worked with same sponsors:

Beijing HospitalChanghai Hospital+21 more
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05998759Phase 2PrincipalInvestigator

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

Connective Tissue DiseasesThrombocytopenia
Recruiting

All 1 trials loaded